PRODUCTS SOLD ON PEPTIDESLABUAE.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.
PRODUCTS SOLD ON PEPTIDESLABUAE.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.
Price range: £23.99 through £98.99
Buy Sermorelin Acetate Peptide in UAE – In Stock & Ready to Ship
Sermorelin Acetate is a widely researched peptide known for its role in growth hormone release and hypothalamic function studies. Each batch is independently verified at ≥99% purity and comes with a full Certificate of Analysis (COA) and HPLC testing documentation — giving UAE research teams the confidence they need when sourcing peptides for serious work.
For research use only. Not intended for human or veterinary use.
Sermorelin Acetate is a synthetic analogue of endogenous Growth Hormone-Releasing Hormone (GHRH), studied extensively in endocrinology research for its ability to stimulate natural growth hormone secretion from the pituitary gland — making it one of the most well-documented and precisely targeted growth hormone axis research peptides available in pre-clinical science. Researchers and institutions across the UAE, Dubai, Abu Dhabi and the wider GCC can source verified, research-grade Sermorelin Acetate with fast international dispatch and full batch documentation included.
✅ ≥99% Purity — HPLC & Mass Spectrometry Verified
✅ Batch-Specific Certificate of Analysis (CoA) Included
✅ Sterile Lyophilised Powder | GMP Manufactured
✅ Fast International Dispatch to UAE & GCC
Sermorelin Acetate is a synthetic peptide corresponding to the first 29 amino acids of endogenous GHRH (Growth Hormone-Releasing Hormone) — the naturally occurring hypothalamic hormone responsible for stimulating the anterior pituitary to produce and release growth hormone. The full endogenous GHRH molecule contains 44 amino acids, but research established that the first 29 residues retain full biological activity at the GHRH receptor, making Sermorelin a functional and more practical research analogue.
As the acetate salt form, Sermorelin Acetate offers improved stability compared to the free base peptide, making it a reliable and consistent research tool for laboratories studying the growth hormone axis. Its mechanism — stimulating the pituitary’s own GH-releasing machinery rather than directly providing exogenous growth hormone — has made it a valuable tool for research examining the hypothalamic-pituitary-somatotropic axis, GH secretion dynamics, and how natural GH release patterns influence downstream metabolic and physiological parameters. Research interest from institutions across the UAE and GCC has grown alongside the expanding regional focus on endocrinology, anti-ageing biology, and metabolic health research.
In controlled laboratory and pre-clinical research settings, Sermorelin Acetate has been studied across a broad range of endocrinology and growth hormone axis research applications:
GHRH Receptor Activation: Sermorelin’s primary research mechanism is its selective activation of the GHRH receptor (GHRHR) on somatotroph cells in the anterior pituitary — the same receptor engaged by endogenous GHRH. Studies use Sermorelin to examine receptor binding kinetics, downstream cAMP signalling cascades, and how GHRHR activation drives GH gene expression and secretion.
Growth Hormone Secretion Studies: Research uses Sermorelin to examine pulsatile GH release patterns, GH secretion amplitude and frequency, and how GHRH receptor stimulation interacts with the inhibitory hormone somatostatin to regulate overall GH output from the pituitary.
Hypothalamic-Pituitary-Somatotropic Axis Research: Sermorelin is used as a research tool to study the HPS axis — the regulatory system connecting hypothalamic GHRH release, pituitary GH secretion, and peripheral IGF-1 production — allowing researchers to examine how this axis responds to stimulation, feedback, and age-related changes.
IGF-1 Axis Studies: Research has examined how Sermorelin-stimulated GH release influences downstream IGF-1 production in the liver and peripheral tissues, contributing to a broader understanding of how the GH/IGF-1 axis mediates growth and metabolic effects.
Age-Related GH Decline Research: Pre-clinical studies have used Sermorelin to examine how GHRH receptor responsiveness changes with ageing, exploring the mechanistic basis of the age-associated decline in GH secretion and how GHRH stimulation affects the ageing pituitary.
Body Composition Research: Animal model studies have examined how GHRH analogue stimulation via Sermorelin influences body composition parameters including lean mass, fat distribution, and metabolic rate markers under controlled experimental conditions.
Bone and Connective Tissue Research: Studies have explored how Sermorelin-stimulated GH and IGF-1 release influences bone formation markers, collagen synthesis parameters, and skeletal tissue metabolism in pre-clinical models.
Sleep and GH Pulsatility Research: Growth hormone is predominantly released during slow-wave sleep, and research has examined Sermorelin in the context of sleep-associated GH pulsatility — exploring the relationship between sleep architecture and natural GH secretion patterns.
All applications listed are research-based only. Sermorelin Acetate is not approved for human therapeutic use as supplied.
Sermorelin Acetate has accumulated an extensive and well-documented pre-clinical research profile spanning several decades:
Foundational pharmacology studies established that the 1–29 fragment of GHRH retains full receptor binding affinity and biological activity at the GHRH receptor, validating Sermorelin as a functionally equivalent research analogue to full-length GHRH and confirming its utility as a practical endocrinology research tool. Pre-clinical GH secretion studies have used Sermorelin to characterise pulsatile GH release dynamics, with research documenting how GHRHR stimulation interacts with somatostatin-mediated inhibition to produce the characteristic pulsatile pattern of GH secretion — providing insights relevant to understanding GH axis regulation in both normal and pathological states. Age-related research has examined Sermorelin in aged animal models, with studies documenting changes in GHRH receptor sensitivity and GH secretion capacity with ageing — contributing to research understanding of somatotropic axis decline and its relationship to age-associated metabolic and body composition changes. Body composition research in pre-clinical models has reported influences on lean mass and fat mass parameters following sustained Sermorelin administration, with studies examining how chronic GHRH receptor stimulation affects tissue composition and metabolic markers over time. Comparative endocrinology studies have positioned Sermorelin alongside other GH secretagogues including Ipamorelin and CJC-1295, with research examining how GHRH receptor agonism compares to and combines with ghrelin receptor agonism in producing GH secretion responses.
| Feature | Sermorelin | CJC-1295 | Ipamorelin | Full GHRH |
|---|---|---|---|---|
| Type | GHRH analogue (1–29) | GHRH analogue (modified) | GH secretagogue | Endogenous GHRH |
| Receptor | GHRHR | GHRHR | GHSR-1a (ghrelin) | GHRHR |
| Half-Life | ~10-20 minutes | Extended (DAC form) | Short | ~7 minutes |
| GH Release Pattern | Pulsatile | Sustained | Pulsatile | Pulsatile |
| Selectivity | GHRHR specific | GHRHR specific | GHSR-1a specific | GHRHR specific |
| Research Use | Acute GHRH axis studies | Sustained GH stimulation | Selective GH release | Reference compound |
| Combined Use | Often paired with Ipamorelin | Often paired with Ipamorelin | Often paired with Sermorelin | — |
| Parameter | Specification |
|---|---|
| Full Name | Sermorelin Acetate |
| Sequence | GHRH (1–29) NH2 — Acetate Salt |
| Length | 29 Amino Acids |
| Receptor Target | GHRHR (GHRH Receptor) |
| Purity | ≥99% (HPLC & MS Verified) |
| Form | Sterile Lyophilised Powder |
| Solubility | Sterile water, bacteriostatic water |
| Storage (powder) | -20°C, protect from light |
| Storage (reconstituted) | 2–8°C, use within 2–4 weeks |
Every order of Sermorelin Acetate dispatched to the UAE and GCC includes:
Can I buy Sermorelin Acetate in the UAE?
Yes. We supply research-grade Sermorelin Acetate with international dispatch to the UAE, Dubai, Abu Dhabi, Sharjah and across the GCC. All orders include full batch documentation and are packaged to maintain peptide integrity throughout transit. This compound is supplied strictly for laboratory research use only.
What is the difference between Sermorelin and full-length GHRH?
Endogenous GHRH contains 44 amino acids, but research established that only the first 29 amino acids are required for full biological activity at the GHRH receptor. Sermorelin corresponds to this active 1–29 fragment, making it functionally equivalent to full GHRH at the receptor level while being a shorter, more stable, and more practical research compound. The acetate salt form further improves stability compared to both full GHRH and the free base peptide form.
How does Sermorelin differ from CJC-1295 in research?
Both Sermorelin and CJC-1295 are GHRH receptor agonists derived from the GHRH sequence, but they differ significantly in half-life and duration of action. Sermorelin has a relatively short half-life making it suited to acute pulsatile GH secretion studies. CJC-1295 — particularly the DAC (Drug Affinity Complex) form — has a greatly extended half-life providing sustained GHRH receptor stimulation. The choice between them depends on whether the research protocol requires acute pulsatile or sustained GH axis stimulation.
Why is Sermorelin often studied alongside Ipamorelin?
Sermorelin and Ipamorelin are frequently combined in research because they stimulate GH release through entirely different receptor systems — Sermorelin through GHRH receptors and Ipamorelin through ghrelin receptors (GHSR-1a). Research examining both together explores whether dual-pathway GH axis stimulation produces synergistic or additive effects on GH secretion amplitude and pulsatility compared to either compound alone.
What purity is required for Sermorelin endocrinology research?
A minimum of ≥98% is considered research grade, though ≥99% is strongly preferred for sensitive GH secretion assays, GHRH receptor binding studies, and hormonal axis experiments where compound purity directly affects pharmacological accuracy and result reproducibility. All our Sermorelin Acetate is independently verified to ≥99% purity.
How is Sermorelin Acetate reconstituted for laboratory use?
Allow the vial to reach room temperature before opening. Add sterile or bacteriostatic water slowly down the vial wall and swirl gently without shaking. Aliquot immediately if longer-term storage at -80°C is required to preserve peptide integrity and avoid freeze-thaw degradation across multiple experimental uses.
How quickly is Sermorelin Acetate delivered to UAE?
Orders are dispatched promptly via tracked international courier. Delivery to the UAE typically takes 3–5 working days, with packaging designed to maintain peptide stability throughout transit.
Research Disclaimer: Sermorelin Acetate is supplied exclusively for legitimate scientific research purposes conducted within licensed laboratory environments. This product is not intended for human consumption, self-administration, or any therapeutic application. It must be handled by qualified researchers in compliance with applicable UAE regulations and institutional ethics guidelines. Handling should only be performed by qualified laboratory professionals in controlled research settings with appropriate institutional authorisations in place. By purchasing, you confirm that this compound will be used solely for approved in-vitro or pre-clinical research purposes.
Receive News
